Response of Mycobacterium smegmatis to the Cytochrome bcc Inhibitor Q203

For the design of next-generation tuberculosis chemotherapy, insight into bacterial defence against drugs is required. Currently, targeting respiration has attracted strong attention for combatting drug-resistant mycobacteria. Q203 (telacebec), an inhibitor of the cytochrome bcc complex in the mycob...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Priyanka, van der Meulen, Santhe Amber, Simões Caetano, João Miguel, Goojani, Hojjat Ghasemi, Botman, Dennis, van Spanning, Rob, Lill, Holger, Bald, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498996/
https://www.ncbi.nlm.nih.gov/pubmed/36142240
http://dx.doi.org/10.3390/ijms231810331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498996/
https://www.ncbi.nlm.nih.gov/pubmed/36142240
http://dx.doi.org/10.3390/ijms231810331

Ejemplares similares